
Oric Pharmaceuticals, Inc.: shareholders and insiders
Price
$7.36
November 20, 2026Market cap $739M
What Ploutos Investor adds for Oric Pharmaceuticals
Part of Ploutos Investor, €9.99 a month
- The full history: 8 fiscal years, from 2018
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 22, 2025 to Oct 21, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$2.9M
4 people
From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan86%
- The rest14%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $2.5M by 2 people
- 2025: no buys, sold $399.5K by 2 people
- 2026: no buys, sold $2.5M by 2 people
- Oct 20, 2026Dominic PiscitelliChief Financial OfficerKind10b5-1
- Oct 20, 2026Dominic PiscitelliChief Financial OfficerKind10b5-1
- Oct 1, 2026Richard A. HeymanDirectorKind10b5-1
- Oct 1, 2026Richard A. HeymanDirectorKind10b5-1
- Oct 1, 2026Richard A. HeymanDirectorKind10b5-1
- Sep 28, 2026Dominic PiscitelliChief Financial OfficerKind10b5-1
- Sep 28, 2026Dominic PiscitelliChief Financial OfficerKind10b5-1
- Sep 24, 2026Dominic PiscitelliChief Financial OfficerKind10b5-1
- Sep 24, 2026Dominic PiscitelliChief Financial OfficerKind10b5-1
- Sep 24, 2026Dominic PiscitelliChief Financial OfficerKind10b5-1
- Aug 26, 2026Dominic PiscitelliChief Financial OfficerKind10b5-1
- Aug 26, 2026Dominic PiscitelliChief Financial OfficerKind10b5-1
- Aug 26, 2026Dominic PiscitelliChief Financial OfficerKind10b5-1
- Jul 24, 2026Richard A. HeymanDirectorKind10b5-1
- Jul 24, 2026Richard A. HeymanDirectorKind10b5-1
- Jul 24, 2026Richard A. HeymanDirectorKind10b5-1
- Jul 6, 2026Richard A. HeymanDirectorKind10b5-1
- Feb 24, 2026Dominic PiscitelliChief Financial OfficerKind10b5-1
- Jan 16, 2026Richard A. HeymanKind10b5-1
- Jan 16, 2026Richard A. HeymanKind10b5-1
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | Dominic PiscitelliChief Financial Officer | 10b5-1 | 14.0K | $4.36 | $61.0K | Form 4 |
| Oct 20, 2026 | Dominic PiscitelliChief Financial Officer | 10b5-1 | 14.0K | $13.53 | $189.4K | Form 4 |
| Oct 1, 2026 | Richard A. HeymanDirector | 10b5-1 | 3,500 | $1.60 | $5.6K | Form 4 |
| Oct 1, 2026 | Richard A. HeymanDirector | 10b5-1 | 3,500 | $12.91 | $45.2K | Form 4 |
| Oct 1, 2026 | Richard A. HeymanDirector | 10b5-1 | 3,200 | $12.91 | $41.3K | Form 4 |
| Sep 28, 2026 | Dominic PiscitelliChief Financial Officer | 10b5-1 | 13.4K | $4.36 | $58.4K | Form 4 |
| Sep 28, 2026 | Dominic PiscitelliChief Financial Officer | 10b5-1 | 13.4K | $13.53 | $181.3K | Form 4 |
| Sep 24, 2026 | Dominic PiscitelliChief Financial Officer | 10b5-1 | 600 | $4.36 | $2.6K | Form 4 |
| Sep 24, 2026 | Dominic PiscitelliChief Financial Officer | 10b5-1 | 100 | $13.50 | $1.4K | Form 4 |
| Sep 24, 2026 | Dominic PiscitelliChief Financial Officer | 10b5-1 | 500 | $13.51 | $6.8K | Form 4 |
| Aug 26, 2026 | Dominic PiscitelliChief Financial Officer | 10b5-1 | 52.0K | $4.36 | $226.7K | Form 4 |
| Aug 26, 2026 | Dominic PiscitelliChief Financial Officer | 10b5-1 | 25.0K | $6.00 | $150.0K | Form 4 |
| Aug 26, 2026 | Dominic PiscitelliChief Financial Officer | 10b5-1 | 77.0K | $13.69 | $1.1M | Form 4 |
| Jul 24, 2026 | Richard A. HeymanDirector | 10b5-1 | 3,500 | $1.60 | $5.6K | Form 4 |
| Jul 24, 2026 | Richard A. HeymanDirector | 10b5-1 | 7,000 | $12.02 | $84.1K | Form 4 |
| Jul 24, 2026 | Richard A. HeymanDirector | 10b5-1 | 6,100 | $12.02 | $73.3K | Form 4 |
| Jul 6, 2026 | Richard A. HeymanDirector | 10b5-1 | 300 | $12.00 | $3.6K | Form 4 |
| Feb 24, 2026 | Dominic PiscitelliChief Financial Officer | 10b5-1 | 52.0K | $13.51 | $702.5K | Form 4 |
| Jan 16, 2026 | Richard A. Heyman | 10b5-1 | 3,500 | $12.00 | $42.0K | Form 4 |
| Jan 16, 2026 | Richard A. Heyman | 10b5-1 | 3,200 | $12.00 | $38.4K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jul 8, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by ORIC's officers and directors from 2020 up to November 21, 2025, 6 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 1 more, back to 2020
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Nextech Crossover I GP S.a. r.l.with 4 more personsShare of class8.40%
- Viking Global Investorswith 9 more personsShare of class7.80%
- EcoR1 Capital, LLCwith 2 more personsShare of class6.90%
- BlackRock, Inc.Share of class5.60%
- T. Rowe Price Associates, Inc.Share of class5.40%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Nextech Crossover I GP S.a. r.l.with 4 more persons | 8.40% | 7.16M | Aug 14, 2025 | 13G/A | |
| Viking Global Investorswith 9 more persons | 7.80% | 8.26M | May 15, 20263 filings since May 15, 2025 | 13G/A | |
| EcoR1 Capital, LLCwith 2 more persons | 6.90% | 6.73M | Aug 5, 2025 | 13G | |
| BlackRock, Inc. | 5.60% | 5.47M | Jan 21, 20262 filings since Jul 17, 2025 | 13G | |
| T. Rowe Price Associates, Inc. | 5.40% | 5.39M | May 15, 2026 | 13G |
Fell to 5% or less (8)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- Venrock Healthcare Capital Partners III, L.P.4.20%May 15, 202613G/A
- Point72 Asset Management, L.P.0.00%May 15, 202613G/A
- Pfizer Inc. (IRS Identification No.: 13-5315170)3.30%May 12, 202613G/A
- The Column Group II, LP3.70%Nov 17, 202513G/A
- Alkeon Capital Management LLC4.60%Nov 13, 202513G/A
- SR One Capital Management, LLC13D4.75%Aug 14, 202513D/A
- Frazier Life Sciences Public Fund, L.P.2.00%May 15, 202513G/A
- FMR3.50%Feb 12, 202513G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Viking Global (Halvorsen)In the quarter-31%
- Citadel Advisors (Griffin)In the quarter-19%
- D.E. ShawIn the quarter+55%
- Millennium Mgmt (Englander)In the quarter+2.2%
- AQR CapitalIn the quarter+64%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Viking Global (Halvorsen) | 3.56M | -31% | $48M | 0.15% |
| Citadel Advisors (Griffin) | 2.11M | -19% | $28M | 0.02% |
| D.E. Shaw | 2.45M | +55% | $33M | 0.02% |
| Millennium Mgmt (Englander) | 713.3K | +2.2% | $9.6M | 0.01% |
| AQR Capital | 588.6K | +64% | $7.9M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 15.4% of its shares outstanding were held short, -5.5% since the report before.
- Shares held short
- 15.42M
- 15.4%
- Since the report before16.32M on Sep 30, 2026
- -5.5%
- 10.5
- 1.47M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 92%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 7.63M
- Nov 15, 2023: Shares held short 8.77M
- Nov 30, 2023: Shares held short 8.92M
- Dec 15, 2023: Shares held short 8.67M
- Dec 29, 2023: Shares held short 8.70M
- Jan 12, 2024: Shares held short 8.71M
- Jan 31, 2024: Shares held short 6.48M
- Feb 15, 2024: Shares held short 6.54M
- Feb 29, 2024: Shares held short 6.49M
- Mar 15, 2024: Shares held short 6.93M
- Mar 28, 2024: Shares held short 8.14M
- Apr 15, 2024: Shares held short 9.42M
- Apr 30, 2024: Shares held short 10.24M
- May 15, 2024: Shares held short 10.62M
- May 31, 2024: Shares held short 10.85M
- Jun 14, 2024: Shares held short 11.21M
- Jun 28, 2024: Shares held short 11.70M
- Jul 15, 2024: Shares held short 11.38M
- Jul 31, 2024: Shares held short 11.92M
- Aug 15, 2024: Shares held short 12.86M
- Aug 30, 2024: Shares held short 12.67M
- Sep 13, 2024: Shares held short 12.38M
- Sep 30, 2024: Shares held short 12.26M
- Oct 15, 2024: Shares held short 12.00M
- Oct 31, 2024: Shares held short 11.65M
- Nov 15, 2024: Shares held short 11.46M
- Nov 29, 2024: Shares held short 11.29M
- Dec 13, 2024: Shares held short 11.21M
- Dec 31, 2024: Shares held short 11.44M
- Jan 15, 2025: Shares held short 10.52M
- Jan 31, 2025: Shares held short 10.45M
- Feb 14, 2025: Shares held short 12.04M
- Feb 28, 2025: Shares held short 13.54M
- Mar 14, 2025: Shares held short 13.97M
- Mar 31, 2025: Shares held short 15.10M
- Apr 15, 2025: Shares held short 13.26M
- Apr 30, 2025: Shares held short 11.19M
- May 15, 2025: Shares held short 11.69M
- May 30, 2025: Shares held short 13.35M
- Jun 13, 2025: Shares held short 12.71M
- Jun 30, 2025: Shares held short 12.58M
- Jul 15, 2025: Shares held short 12.29M
- Jul 31, 2025: Shares held short 6.76M
- Aug 15, 2025: Shares held short 7.20M
- Aug 29, 2025: Shares held short 8.17M
- Sep 15, 2025: Shares held short 9.53M
- Sep 30, 2025: Shares held short 11.24M
- Oct 15, 2025: Shares held short 13.02M
- Oct 31, 2025: Shares held short 15.49M
- Nov 14, 2025: Shares held short 16.25M
- Nov 28, 2025: Shares held short 17.57M
- Dec 15, 2025: Shares held short 17.96M
- Dec 31, 2025: Shares held short 21.47M
- Jan 15, 2026: Shares held short 21.14M
- Jan 30, 2026: Shares held short 21.65M
- Feb 13, 2026: Shares held short 22.10M
- Feb 27, 2026: Shares held short 21.79M
- Mar 13, 2026: Shares held short 20.65M
- Mar 31, 2026: Shares held short 19.35M
- Apr 15, 2026: Shares held short 20.74M
- Apr 30, 2026: Shares held short 22.01M
- May 15, 2026: Shares held short 21.94M
- May 29, 2026: Shares held short 21.94M
- Jun 15, 2026: Shares held short 21.06M
- Jun 30, 2026: Shares held short 22.11M
- Jul 15, 2026: Shares held short 22.05M
- Jul 31, 2026: Shares held short 21.80M
- Aug 14, 2026: Shares held short 18.39M
- Aug 31, 2026: Shares held short 17.27M
- Sep 15, 2026: Shares held short 17.53M
- Sep 30, 2026: Shares held short 16.32M
- Oct 15, 2026: Shares held short 15.42M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading56.7% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 56.7% of the shares in the reported trades were short sales, against 40.7% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 56.7%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 40.7%
- Change
- +16.0 pts
- Short sales a dayon average, of 454.2K shares
- 257.5K
- More than atof 3,666 US-listed companies, same days
- 73%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 44.5%
- Oct 15, 2026: Short sales 64.6%
- Oct 16, 2026: Short sales 62.9%
- Oct 19, 2026: Short sales 67.8%
- Oct 20, 2026: Short sales 52.9%
- Oct 21, 2026: Short sales 29.7%
- Oct 22, 2026: Short sales 58.1%
- Oct 23, 2026: Short sales 44.3%
- Oct 26, 2026: Short sales 32.2%
- Oct 27, 2026: Short sales 23.1%
- Oct 28, 2026: Short sales 52.8%
- Oct 29, 2026: Short sales 54.3%
- Oct 30, 2026: Short sales 55.5%
- Nov 2, 2026: Short sales 48.1%
- Nov 3, 2026: Short sales 70.3%
- Nov 4, 2026: Short sales 72.4%
- Nov 5, 2026: Short sales 54.9%
- Nov 6, 2026: Short sales 56.2%
- Nov 9, 2026: Short sales 43.1%
- Nov 10, 2026: Short sales 34%
- Nov 11, 2026: Short sales 57%
- Nov 12, 2026: Short sales 54.1%
- Nov 13, 2026: Short sales 44.9%
- Nov 16, 2026: Short sales 61.5%
- Nov 17, 2026: Short sales 51.9%
- Nov 18, 2026: Short sales 45.1%
- Nov 19, 2026: Short sales 58.3%
- Nov 20, 2026: Short sales 32.7%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Jacob ChackoPRESIDENT AND CEODirectly581.7K
- Richard A. HeymanDirectorDirectly35.1K
- Dominic PiscitelliChief Financial OfficerDirectly69.8K
- Pratik S MultaniChief Medical OfficerDirectly68.1K
- Angie YouDirectorDirectly28.0K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Jacob ChackoPRESIDENT AND CEO | 581.7K | – | Dec 16, 2025 | Form 4 |
| Richard A. HeymanDirector | 35.1K | 206.7K | Oct 1, 2026 | Form 4 |
| Dominic PiscitelliChief Financial Officer | 69.8K | – | Oct 20, 2026 | Form 4 |
| Pratik S MultaniChief Medical Officer | 68.1K | – | Dec 16, 2025 | Form 4 |
| Angie YouDirector | 28.0K | – | Jun 23, 2025 | Form 4 |
A lower bound: it counts only the 5 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- XBIState Street(R) SPDR(R) S&P(R) Biotech ETFWeight in the fund0.33%
- LABUDirexion Daily S&P Biotech Bull 3X SharesWeight in the fund0.25%
- IWCiShares Micro-Cap ETFWeight in the fund0.18%
- FESMFidelity Enhanced Small Cap Core ETFWeight in the fund0.06%
- IBBiShares Biotechnology ETFWeight in the fund0.05%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.04%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.03%
- IWMiShares Russell 2000 ETFWeight in the fund0.03%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.02%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.02%
22 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 152
- Q4 2025: Managers 165
- Q1 2026: Managers 183
- Q2 2026: Managers 181
Institutional investors by quarter
The fund managers holding ORIC, quarter by quarter, from Q2 2020 to Q2 2025, 21 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 181 managers held 124M shares, worth $1.3B. During the quarter 31 opened a position, 33 closed one, 80 added and 41 trimmed.
The largest holders, Q2 2026
- Nextech InvestIn the quarter
- BlackRockIn the quarter+14%
- EcoR1 CapitalIn the quarter
- Price T Rowe AssociatesIn the quarter+23%
- Viking Global (Halvorsen)In the quarter-12%
- State StreetIn the quarter+32%
- SR One Capital ManagementIn the quarter+2.2%
- Venrock AdviserIn the quarter
- NEA ManagementIn the quarter
- Vanguard Capital ManagementIn the quarter+7.2%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Nextech Invest | 7.16M | $78M | |
| BlackRock | 6.82M | +14% | $74M |
| EcoR1 Capital | 6.73M | $73M | |
| Price T Rowe Associates | 6.62M | +23% | $72M |
| Viking Global (Halvorsen) | 5.13M | -12% | $56M |
| State Street | 4.89M | +32% | $53M |
| SR One Capital Management | 4.62M | +2.2% | $50M |
| Venrock Adviser | 4.32M | $47M | |
| NEA Management | 4.12M | $45M | |
| Vanguard Capital Management | 3.95M | +7.2% | $43M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Oric Pharmaceuticals's filings show?
Who buys and sells is one part of Oric Pharmaceuticals's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have ORIC's insiders bought or sold?
From Jul 8, 2026 to Oct 21, 2026 Oric Pharmaceuticals's insiders bought 0 and sold $1.7M of shares on the market. 100% of the sales were under set 10b5-1 plans.
Which well-known managers hold ORIC?
5 of the managers we track held the shares on Sep 30, 2026. The largest position was Viking Global (Halvorsen)'s, worth $48M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.